Microbot Medical Inc.
Microbot Medical Inc. (NASDAQ: MBOT) is trading at $1.25, about ₹120 at today's USD/INR rate, as of 28 Sep 2026, 4:00 PM ET, down 1.96% today. Indian residents can buy Microbot Medical from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$1.24
Today's high
$1.28
52 week low
$1.24
52 week high
$3.46
MBOT opened at $1.27, closed previously at $1.28, and has traded between $1.24 and $3.46 over the past 52 weeks.
About
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications. Additionally, Microbot Medical maintains a robust, multi-generational product pipeline. Its global intellectual property portfolio is substantial, encompassing 42 granted or allowed patents and an additional 23 patent applications currently under review. The company also benefits from a strategic collaboration agreement with Stryker Corporation, focusing on joint technology development. Established in 2010, Microbot Medical Inc. is headquartered in Hingham, Massachusetts.
Key statistics
Avg. volume
1.12M
Market cap
$56.96M
P/E Ratio
-4.79
Price-to-sales ratio
164.63
Enterprise value
$54.69M
Free cash flow yield
-31.47%
Debt-to-equity ratio
0.01
Return on equity
-21.87%
ROIC
-26.51%
Beta
1.03
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$0.00
Earnings per share
-$0.29
Free cash flow
-$13.11M
Net profit margin
-4722.25%
Gross margin
-185.26%
EBITDA
-$13.10M
Revenue growth
—
Similar securities
This is not an investment recommendation
How to buy Microbot Medical from India
Indian residents can buy Microbot Medical shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Microbot Medical and place an order
Find Microbot Medical by name or by its ticker, MBOT, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Microbot Medical trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Microbot Medical position in USD and INR. Microbot Medical pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Microbot Medical from India
Trading and taxes when buying Microbot Medical from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneMicrobot Medical does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Microbot Medical stock?
Yes. Microbot Medical (MBOT) has been listed on NASDAQ since 1992, in the Medical - Devices industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Microbot Medical share cost in rupees?
One Microbot Medical share is $1.25 — about ₹120 at a USD/INR rate of 95.93 on 27 Sep 2026. Both the Microbot Medical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Microbot Medical from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Microbot Medical?
Yes. One Microbot Medical share is $1.25, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Microbot Medical.
How are gains on Microbot Medical shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Microbot Medical price. Paasa issues a capital-gains statement for your return.
Does Microbot Medical pay a dividend?
No. Microbot Medical does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Microbot Medical from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Microbot Medical shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Microbot Medical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Microbot Medical holding, its cost and its closing value.
How do I sell Microbot Medical and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.